[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:cancer-testis-antigen-1":3},{"name":4,"total":5,"recruiting":6,"trials":7},"Cancer\u002FTestis Antigen 1",4,2,[8,16,22,30],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05989828","A2-ESO-1 TCR-Engineered T Cells for Relapsed\u002FRefractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer",[12],"Phase 1","RECRUITING","2026-08-26T02:16:21.385056Z","2026-05-29T15:36:40.167133Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06083883","Phase I\u002FIb Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1",[12],"2026-08-26T02:18:26.129155Z","2026-04-29T02:57:57.066842Z",{"nct_id":23,"title":24,"phases":25,"status":27,"updated_at":28,"content_modified":29},"NCT07389239","A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.",[26],"Phase 1\u002FPhase 2","NOT_YET_RECRUITING","2026-08-26T02:19:15.498463Z","2026-05-05T02:43:29.075289Z",{"nct_id":31,"title":32,"phases":33,"status":27,"updated_at":34,"content_modified":35},"NCT06748872","EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And\u002For Synovial Sarcoma",[12],"2026-08-26T02:15:03.757872Z","2026-05-05T02:43:28.536530Z"]